PAPER Hosseinpouri A, Sadegh K, Zarei-Behjani Z, Dehghan Z, Karbalaei R

Identification of critical genes and drug repurposing targets in entorhinal cortex of Alzheimer's disease.

Neurogenetics. 2025 Feb 10;26(1):27. PubMed.

PAPER Hu M, Ye J

Clinical efficacy of donepezil combined with nerve growth factor in the treatment of patients with Parkinson's disease dementia and its impact on adiponectin and soluble tumor necrosis factor-alpha receptor-1.

Pak J Med Sci. 2025 Feb;41(2):372-377. PubMed.

PAPER

Correction to: Brain aging rejuvenation factors in adults with genetic and sporadic neurodegenerative disease.

Brain Commun. 2025;7(1):fcaf058. Epub 2025 Feb 7 PubMed. Corrected paper.

PAPER Liu L, He H, Du B, He Y

Nanoscale drug formulations for the treatment of Alzheimer's disease progression.

RSC Adv. 2025 Feb 6;15(6):4031-4078. Epub 2025 Feb 7 PubMed.

PAPER Romero-ElKhayat L, Dakterzada F, Huerto R, Carnes-Vendrell A, Mínguez O, Pujol Sabaté M, Targa A, Barbé F, Milanesi E, Dobre M, Manda G, Cuadrado A, Piñol-Ripoll G

Inflammatory and Redox Blood Gene Expression Fingerprint of Severe Obstructive Sleep Apnoea in Patients With Mild Alzheimer's Disease.

J Inflamm Res. 2025;18:1609-1621. Epub 2025 Feb 4 PubMed.

PAPER Bindra S, Mostafa EM, Abdelgawad MA, Selim S, Kumar S, Mathew B

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors.

RSC Med Chem. 2025 Feb 6; Epub 2025 Feb 6 PubMed.

PAPER Williams LA, Terhorst L, Williams IC, Skidmore E, Lingler JH

Perceived risk of Alzheimer's disease: Insights into the Black and African American male perspective.

J Alzheimers Dis. 2025 Feb 9;:13872877251317151. Epub 2025 Feb 9 PubMed.

PAPER Taweephol T, Pongpitakmetha T, Booncharoen K, Khieukhajee J, Luechaipanit W, Haethaisong T, Chongsuksantikul A, Likitjaroen Y, Thanapornsangsuth P

Short communication: Evaluating roles of plasma glial fibrillary acidic protein as Alzheimer's disease biomarker in real-world multi-center memory clinics in Thailand.

J Alzheimers Dis. 2025 Feb 9;:13872877251316546. Epub 2025 Feb 9 PubMed.

PAPER Liu S, Geng D

White-Matter Structural Connectivity and Alzheimer's Disease: A Mendelian Randomization Study.

Brain Behav. 2025 Feb;15(2):e70286. PubMed.

PAPER Shang J, Liu T, Gong W, Zhao Y

Exploring the bidirectional relationships between alzheimer's disease and cerebral small vessel disease: Insights from mendelian randomization.

J Stroke Cerebrovasc Dis. 2025 Apr;34(4):108259. Epub 2025 Feb 8 PubMed.

PAPER Aman Y

Effect of cholinergic modulator in Parkinson's disease with cognitive impairment.

Nat Aging. 2025 Feb;5(2):177. PubMed.

PAPER Islam T, Hill E, Abrahamson EE, Servaes S, Smirnov DS, Zeng X, Sehrawat A, Chen Y, Kac PR, Kvartsberg H, Olsson M, Sjons E, Gonzalez-Ortiz F, Therriault J, Tissot C, Del Popolo I, Rahmouni N, Richardson A, Mitchell V, Zetterberg H, Pascoal TA, Lashley T, Wall MJ, Galasko D, Rosa-Neto P, Ikonomovic MD, Blennow K, Karikari TK

Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's disease.

Nat Med. 2025 Feb;31(2):574-588. Epub 2025 Feb 10 PubMed.

PAPER Singh A, Maheshwari S, Yadav JP, Kumar R, Verma A, Singh S, Prajapati BG

Bioactive Compound-Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review.

Chem Biodivers. 2025 Feb 10;:e202402018. Epub 2025 Feb 10 PubMed.

PAPER VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini ML, Heuer HW, Kramer JH, Lario Lago A, Leichter D, Ljubenkov P, Miller BL, Perry DC, Rabinovici GD, Rojas JC, Rosen HJ, Saloner R, Staffaroni A, Triana-Baltzer G, Spina S, Seeley WW, Grinberg LT, Kolb HC, La Joie R, Boxer AL

Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers.

JAMA Neurol. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Park CH, Lee H, Lee YM, Lee BD, Moon E, Suh H, Kim K, Kim HJ, Shim H, Pak K, Choi KU, Kim CS

Sex-specific effects of apolipoprotein E ε4 genotype on longitudinal hippocampal atrophy in amnestic mild cognitive impairment over a 2-year evaluation period.

J Alzheimers Dis. 2025 Feb;103(4):1269-1276. Epub 2025 Feb 9 PubMed.